HESTERBIO stock exhibits moderate to high volatility typical of small-cap pharmaceutical and biotechnology equities listed on Indian stock exchanges. Share price fluctuations are driven by quarterly financial earnings reports, seasonal variations in animal vaccine procurement, export market expansions in Africa, and broader macroeconomic sentiment shifts affecting the domestic healthcare sector, requiring investors to maintain a long-term risk perspective.